Decarbonize the healthcare sector and make healthcare facilities more resilient to the effects of climate change. It is the goal that Biden Administration’s wants to achieve reducing emissions by 50% by 2030 and achieving net zero emissions by 2050.
A goal perfectly in line with those of the Chiesi Group, officially declared through the #ActionOverWords campaign. For this reason, the Group signed back in June the White House pledge.
In this sense, we appreciate the recognition from the U.S. Department of Health and Human Services (HHS) at the 2022 United Nations Climate Change Conference (COP27) on Nov. 10 and celebrate that we are part of a community of already 102 prominent health companies that have signed the White House/HHS Health Sector Climate Pledge, including organizations representing 837 hospitals as well as leading health centers, suppliers, insurance companies, group purchasing organizations, pharmaceutical companies and more.
The objectives of the Group, a Benefit Corporation in Italy, the United States and France and a B Corp certified company, are clear: to become Net Zero by 2035, by reducing as much as possible greenhouse gases emissions and neutralizing only residual emissions.
As a practical example, Chiesi realized that a large part of its impact derives from the propellant contained in the inhalers for the delivery of products for the treatment of asthma and COPD. The company is now working on a total re-engineering and clinical development of a carbon minimal inhaler, with an investment of 350 million euros over 7 years. This effort will reduce the carbon footprint of this products by up to 90%.
Chiesi is committed to further advancing toward its net-zero goals while continuing to provide high-quality care for patients. The company believes this is the only possible way forward to guarantee sustainable access to healthcare in the future.
In addition to this complex research and development project, Chiesi has also started to promote pilot initiatives for the proper disposal of expired or spent inhalers, which is a possible further source of residual propellant gas emissions.
In the UK, in the Leichester region, Chiesi is promoting “TAKE AIR”, a scheme to take back inhalers of all types and brands by pole. In Italy, in the Friuli Venezia Giulia region, the "Recupera e Respira" project has recently been activated, which sees the pharmacist as the point of reference for the collection and proper disposal of all exhausted inhalers.
Along with committing to this pledge, Chiesi Group released its 2021 Annual and Sustainability Report tracking the actions taken to conduct its business more sustainably and responsibly.
For more information about how Chiesi Group is responding to the climate challenges, visit the #ActionOverWords website.